23 March 2021
Event date and time: Wednesday 7 April 2021, 09.00 - 10.00 BST.
5 March 2021
Statement from the RECOVERY trial chief investigators, 5 March 2021
RECOVERY trial closes recruitment to convalescent plasma treatment for patients hospitalised with COVID-19
15 January 2021
Statement from the RECOVERY trial chief investigators, 15 January 2021
11 January 2021
Statement from the RECOVERY trial chief investigators, 11 January 2021
14 December 2020
Statement from the Chief Investigators of the Randomised Evaluation of COVid-19 thERapY (RECOVERY) Trial on azithromycin, 14 December 2020
30 November 2020
The RECOVERY trial has been selected as one of ten finalists in the Special COVID-19 response category in the 2020 National Project Awards, organised by PMI UK, in association with PricewaterhouseCoopers (PwC).
RECOVERY COVID-19 phase 3 trial to evaluate Regeneron’s REGN-COV2 investigational antibody cocktail in the UK
14 September 2020
One of the world’s largest efforts to find effective COVID-19 treatments will evaluate the impact of REGN-COV2 on mortality, hospital stays, and the need for ventilation.